Ubs Group Ag Cti Biopharma Corp Transaction History

Ubs Group Ag

  • $400 Billion
  • Q2 2024

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2023

May 12, 2023
SELL
$4.2 - $6.01 $2.2 Million - $3.15 Million
-523,416 Reduced 56.51%
402,893 $1.69 Million
Q4 2022

Feb 08, 2023
BUY
$4.45 - $6.17 $3.48 Million - $4.83 Million
782,053 Added 542.13%
926,309 $5.57 Million
Q3 2022

Nov 10, 2022
SELL
$5.36 - $7.43 $714,187 - $990,002
-133,244 Reduced 48.02%
144,256 $840,000
Q2 2022

Aug 10, 2022
BUY
$3.55 - $6.27 $925,719 - $1.64 Million
260,766 Added 1558.3%
277,500 $1.66 Million
Q1 2022

May 16, 2022
BUY
$1.9 - $5.23 $24,162 - $66,509
12,717 Added 316.58%
16,734 $78,000
Q4 2021

Feb 14, 2022
SELL
$1.44 - $2.86 $375 - $746
-261 Reduced 6.1%
4,017 $10,000
Q3 2021

Nov 15, 2021
SELL
$2.25 - $3.18 $5,555 - $7,851
-2,469 Reduced 36.59%
4,278 $13,000
Q2 2021

Aug 13, 2021
SELL
$2.16 - $2.62 $6,963 - $8,446
-3,224 Reduced 32.33%
6,747 $17,000
Q1 2021

May 12, 2021
BUY
$2.68 - $3.8 $15,257 - $21,633
5,693 Added 133.08%
9,971 $29,000
Q4 2020

Feb 11, 2021
SELL
$2.48 - $3.8 $1,448 - $2,219
-584 Reduced 12.01%
4,278 $14,000
Q3 2020

Nov 12, 2020
SELL
$1.02 - $2.15 $21,420 - $45,150
-21,000 Reduced 81.2%
4,862 $10,000
Q2 2020

Jul 31, 2020
BUY
$0.88 - $1.32 $7,211 - $10,817
8,195 Added 46.39%
25,862 $30,000
Q1 2020

May 01, 2020
BUY
$0.69 - $1.54 $5,701 - $12,725
8,263 Added 87.87%
17,667 $16,000
Q4 2019

Feb 14, 2020
BUY
$0.72 - $1.64 $3,836 - $8,737
5,328 Added 130.72%
9,404 $15,000
Q3 2019

Nov 14, 2019
SELL
$0.64 - $0.92 $2,629 - $3,780
-4,109 Reduced 50.2%
4,076 $3,000
Q2 2019

Aug 14, 2019
BUY
$0.8 - $1.03 $1,804 - $2,322
2,255 Added 38.03%
8,185 $7,000
Q1 2019

May 14, 2019
SELL
$0.9 - $1.37 $23,805 - $36,237
-26,451 Reduced 81.69%
5,930 $6,000
Q4 2018

Feb 14, 2019
BUY
$0.73 - $2.19 $4,800 - $14,401
6,576 Added 25.48%
32,381 $24,000
Q3 2018

Nov 14, 2018
BUY
$1.72 - $5.24 $9,284 - $28,285
5,398 Added 26.45%
25,805 $56,000
Q2 2018

Aug 14, 2018
BUY
$3.81 - $5.26 $20,010 - $27,625
5,252 Added 34.66%
20,407 $101,000
Q1 2018

May 15, 2018
BUY
$2.7 - $4.06 $10,743 - $16,154
3,979 Added 35.6%
15,155 $59,000
Q4 2017

Feb 14, 2018
BUY
$2.47 - $3.34 $9,813 - $13,269
3,973 Added 55.16%
11,176 $30,000
Q3 2017

Nov 14, 2017
BUY
$3.12 - $3.65 $8,938 - $10,457
2,865 Added 66.04%
7,203 $23,000
Q2 2017

Aug 14, 2017
SELL
N/A
-479 Reduced 9.94%
4,338 $14,000
Q1 2017

Nov 14, 2017
BUY
N/A
4,817
4,817 $20,000

About CTI BIOPHARMA CORP

CTIC Quotes by TradingView
  • Ticker CTIC
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 114,385,000
  • Market Cap $1.04B
  • Description
  • CTI BioPharma Corp., a biopharmaceutical company, focuses on the acquisition, development, and commercialization of novel targeted therapies for blood-related cancers in the United States. It offers VONJO (pacritinib), an investigational oral kinase inhibitor with specificity for JAK2, FLT3, IRAK1, and CSF1R for the treatment of adult patients w...
More about CTIC
Track This Portfolio

Track Ubs Group Ag Portfolio

Follow Ubs Group Ag and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Ubs Group Ag, based on Form 13F filings with the SEC.

News

Stay updated on Ubs Group Ag with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email